ResearchMoz

Espicom Market Research Reports

With over 30 years of continuous research and editorial experience in the global health industry, Espicom is one of the longest established independent business intelligence providers operating today. 
Espicom produces original analysis, news and forecasts using its skilled and experienced team of more than 30 full-time in-house analysts, researchers and editorial experts. With a combined experience of over 200 years they cover key disciplines including pharmacology, biosciences, economics statistics and languages. In addition, a select group of experts are on hand in respect of specialist scientific/technology areas. We do not use freelancers or subcontractors to produce our class leading subscription and intelligence services. This gives us control and you confidence. 

List of reports from Espicom

Displaying 1 to 30 (of 196 records)
The Pharmaceutical Market: South Africa
Jul 2014  
OVERVIEW OF THE PHARMACEUTICAL MARKET IN SOUTH AFRICA The government drive to support local production and reduce the country's reliance on imports, in addition to global epidemiological and demographic trends, are all positive factors contributing to long-term growth in the pharmaceutical market. However, deep segregation between private and public healthcare facilities...
$1295
The Pharmaceutical Market: United Arab Emirates
Jul 2014  
OVERVIEW OF THE PHARMACEUTICAL MARKET IN UNITED ARAB EMIRATES The United Arab Emirates'healthcare and pharmaceutical markets continue to be thestrongest in the region.Its growth prospects arestrong -we forecast high single-digit CAGRsover the course of our 10-year forecast period. Several factors are driving growth: incomes are high, as isthe UAE's expatriate population.These...
$1295
The Pharmaceutical Market: Qatar
Jul 2014  
Qatar Pharmaceuticals & Healthcare Report According to recent reports in The Gulf Times, Qatar will have four new drug manufacturers by the end of Q113. The drugmakers will reportedly import their raw materials and produce tablets, syrups and injectables. It is anticipated the drug manufacturers will (in our view eventually) help curb reliance on imports and lower prices...
$1295
The Medical Device Market: USA
Jul 2014  
OVERVIEW OF THE MEDICAL MARKET IN THE USA At an estimated US$127.1bn in 2013, the US medical device market is the world's largest. Per capita expenditure, at US$399, is the highest in the world. Much of the market is in private hands; there is no single health system. Public healthcare systems, known as Medicaid, for those on low incomes, are operated by each State....
$1295
The Pharmaceutical Market: Slovakia
Jul 2014  
OVERVIEW OF THE PHARMACEUTICAL MARKET IN SLOVAKIA Slovak Prime Minister Robert Fico plans to unify the country'sprivate and public health insurance funds into a single state-owned insurer, but there is likely to be a lengthy negotiation and a legal battle before this is realised. We do not expect either of the two private insurers - Dôvera or Dutch-owned Union - will...
$1295
The Medical Device Market: Bangladesh
Jul 2014  
OVERVIEW OF THE MEDICAL MARKET IN BANGLADESH Bangladesh remains one of the poorest countries in the world. Poverty is widespread throughout and GDP is extremely low, despite it being the eighth most populous country on earth. Frequent large scale flooding also remains a constant threat. Government funding is low and the country continues to rely on international aid. An...
$1295
The Pharmaceutical Market: Ghana
Jul 2014  
Ghana Pharmaceuticals & Healthcare Report We remain of the view that Ghana will be a regional outperformer in terms of the development of its pharmaceutical and healthcare markets over the medium to longer term . On the other hand, reliance on donations and foreign aid to provide some of the medical services and treatments will continue to negatively impact the development...
$1295
The Medical Device Market: Germany
Jul 2014  
OVERVIEW OF THE MEDICAL MARKET IN GERMANY Germany has one of the most advanced economies in the world. GDP is estimated at US$3.6trn in 2013, equal to around US$44,000 per capita, making the German economy the fourth largest, behind the USA, China and Japan. As one of the world's largest exporters, the German economy has been hard hit by the poor global economic climate...
$1295
The Medical Device Market: Romania
Jul 2014  
OVERVIEW OF THE MEDICAL MARKET IN ROMANIA Romania spends around 5.8% of GDP on healthcare. Government health expenditure is very low, even by Eastern European standards. However, improvements to the health system continue to be supported by World Bank-sponsored projects. The 'Health Sector Reform Project APL II', was approved in December 2004 and will run until December 2013....
$1295
The Pharmaceutical Market: Indonesia
Jul 2014  
OVERVIEW OF THE PHARMACEUTICAL MARKET IN INDONESIA Indonesia's new goal to establish universal healthcare coverage by 2019 rather than 2014 is more feasible given that the programme will be rolled out in phases. We continue to see universal healthcare coverage as a key theme in Asia, although poor governance in several countries across the region will delayitsimplementation....
$1295
The Pharmaceutical Market: Norway
Jul 2014  
OVERVIEW OF THE PHARMACEUTICAL MARKET IN NORWAY The macroenvironment for the Norwegian pharmaceutical industry is improving. Politically, the centre-left coalition is expected to hold together at least until the general election in September 2013, but the risk of the coalition breaking up has grown. Economically, the recession was far less pronounced in Norway than in most...
$1295
The Pharmaceutical Market: Vietnam
Jul 2014  
OVERVIEW OF THE PHARMACEUTICAL MARKET IN VIETNAM Corruption will continue to affect Vietnam's pharmaceutical and healthcare business environment and potentially delay the introduction of universal healthcare coverage for its people. While corruption is a clear downside risk, we maintain that the sector still offers strong growth opportunities for foreign investors....
$1295
The Medical Device Market: Austria
Jul 2014  
OVERVIEW OF THE MEDICAL MARKET IN AUSTRIA Although a relatively small market, Austria has a high level of per capita spending on medical devices. The market for medical equipment and supplies is valued at US$2,527mn in 2013, equal to US$299 per capita. Austria is a federal republic, comprising nine constituent federal states: Burgenland, Carinthia, Lower Austria, Salzburg,...
$1295
The Medical Device Market: Colombia
Jul 2014  
OVERVIEW OF THE MEDICAL MARKET IN COLOMBIA Colombia is the third most populous country in Latin America, behind Brazil and Mexico, with a population of 48mn. The capital, Santa Fe de Bogotá, has a population of around 7mn. The population is relatively young and growing rapidly thanks to a high birth rate and a low mortality rate. Colombia is the fourth largest...
$1295
The Medical Device Market: Poland
Jun 2014  
OVERVIEW OF THE MEDICAL MARKET IN POLAND Poland has the second largest economy in Central & Eastern Europe, although in per capita terms it is around average. According to BMI, GDP is estimated at US$529.0bn in 2013 and is expected to increase by an average 3.5% per annum between 2014 and 2018, reaching US$733.7bn. GDP per capita will rise from US$13,800 in 2013...
$1295
The Pharmaceutical Market: Cuba
Jun 2014  
OVERVIEW OF THE PHARMACEUTICAL MARKET IN CUBA Cuban health expenditure is the lowest in the Americas region. Nearly all health expenditure will be accountable to the public sector in the 2011-2016 period. Due to fluctuating GDP rates, expenditure as a percentage of GDP is expected to oscillate between 11.6% and 12.9% in the forecast period. Given that all medical care is...
$1295
The Pharmaceutical Market: USA
Jun 2014  
OVERVIEW OF THE PHARMACEUTICAL MARKET IN THE USA Despite assertions from some stakeholders, the r e-election of Barack Obama as President of the United States is not bad news for pharmaceutical companies and medical device manufacturers, primarily because we expect continuation of existing policies that have generally been favourable. However, we caution that further reforms...
$1295
The Pharmaceutical Market: Chile
Jun 2014  
OVERVIEW OF THE PHARMACEUTICAL MARKET IN CHILE Pharmaceutical companies will continue to look to fast growing emerging markets for revenue growth, and we believe that Latin American economies, with rising incomes, ageing populations and increased spending on healthcare will provide significant opportunities. Indeed, it is our view that emerging markets will be the...
$1295
The Pharmaceutical Market: Ireland
Jun 2014  
THE PHARMACEUTICAL MARKET: IRELAND - REVIEW Ireland has experienced rapid economic growth over the past 20 years, and has invested in large scale renovation and redevelopment of its healthcare infrastructure. That said, the country is in the midst of a severe economic downturn, with GDP expected to contract in 2012. Due to the recession and Ireland’s huge budget deficit,...
$1295
The Medical Device Market: Argentina
Jun 2014  
OVERVIEW OF THE MEDICAL MARKET IN ARGENTINA Espicom Industry View: TheArgentinemedical device marketranks fifth in Latin America. Espicom forecasts a high 2013-2018 CAGR of 10.9% in US dollar terms, fuelled by increasing health expenditure. Medical device imports areveryhigh, althougharelatively large domestic medical device sectoris operational.The country has recovered from...
$1295
The Medical Device Market: Belarus
Jun 2014  
OVERVIEW OF THE MEDICAL MARKET IN BELARUS The Belarusian medical device market is small and under-developed. Key metrics, such as health expenditure per capita and medical device spending, are the lowest in Europe. An ailing economy and a political regime resistant to market modernisation, and therefore unattractive to investors, are both dominating factors which limit the...
$1295
The Pharmaceutical Market: Uzbekistan
Jun 2014  
Uzbekistan Pharmaceuticals & Healthcare Report We maintain the view that risk-averse pharmaceutical, healthcare and medical device companies should avoid Uzbekistan . While the country has a definite need for pharmaceuticals and medical devices, the regulatory environment remains opaque and state-dominated. Moreover, the government is committed to boosting Uzbekistan's...
$1295
The Pharmaceutical Market: China
Jun 2014  
OVERVIEW OF THE PHARMACEUTICAL MARKET IN CHINA We remain bullish on China's pharmaceutical sector despite the slowdown in the economy and political reshuffle. We do not think the reshuffle will have any adverse changes or cause any reversals to healthcare reform given that the country has been rolling out various healthcare schemes in 2012 and that a key person overseeing...
$1295
The Pharmaceutical Market: Botswana
Jun 2014  
OVERVIEW OF THE PHARMACEUTICAL MARKET IN BOTSWANA Growing appreciation of the value of a healthy population, combined with improvements in its economy, will boost investments in medical services. The healthcare system is largely government-funded, and therefore people on low incomes are able to seek medical treatment. However, communication and transport hindrances as well as...
$1295
The Pharmaceutical Market: Estonia
May 2014  
THE PHARMACEUTICAL MARKET: ESTONIA - REVIEW Our outlook for the Estonian pharmaceutical market remains unchanged. While epidemiological trends will continue to stimulate the volume development of the market, patent expirations and government encouragement of the consumption of cheaper generic medicine will hamper value growth. The market will remain reliant on imports, which...
$1295
The Medical Device Market: South Korea
May 2014  
OVERVIEW OF THE MEDICAL MARKET IN SOUTH KOREA South Korea ranks as one of the world's leading economies, with a population approaching 50 million and overall GDP listed among the top 15 in the world at an estimated US$1,212 billion in 2013, equal to US$24,843 per capita,. As a result, much of the population expects a high level of medical care. The economy is expected...
$1295
The Pharmaceutical Market: Algeria
May 2014  
Algeria Pharmaceuticals & Healthcare Report We remain optimistic about Algeria 's longer term potential as a pharmaceutical market, underpinned by economic and demographic factors. Our view is supported by a number of investments into the local manufacturing sector made by foreign players in recent months, in partnerships with local companies. However, the country does...
$1295
The Pharmaceutical Market: Angola
May 2014  
Angola Pharmaceuticals & Healthcare Report Since re-election in August 2012, incumbent President Dos Santos has promised considerable investment in Angola's healthcare and pharmaceutical market. With plans for new hospitals announced - including one expansion financed with Chinese funds - as well as the creation of mini laboratories to conduct quality checks on drugs, the...
$1295
The Pharmaceutical Market: Argentina
May 2014  
Argentina Pharmaceuticals & Healthcare Report Argentina's pharmaceutical market will become increasingly unattractive to multinational pharmaceutical companies, as the double-digit market growth has been mainly driven by the high inflation rate. The strict currency and import restrictions, as well as poor regulatory regime, have further undermined foreign drugmakers'...
$1295
The Pharmaceutical Market: Bulgaria
May 2014  
OVERVIEW OF THE PHARMACEUTICAL MARKET IN BULGARIA The Bulgarian government is planning to earmark some BGN150-160mn (US$98.65-105.23mn) in additional funding for healthcare in 2013, the government's press service cited Prime Minister Boyko Borisov as saying in October 2012 . The funds are expected to be used to purchase new equipment, upgrade hospitals and general ly improve...
$1295
 
Displaying 1 to 30 (of 196 records)

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData